Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Goodner

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2002
Phase I study of rubitecan and gemcitabine in patients with advanced malignanciesP M Fracasso, J S Rader, R Govindan, et al.
British Journal of Cancer|June 9, 2005
Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodarP M Fracasso, K A Blum, M K Ma, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2002
Phase I study of rubitecan and gemcitabine in patients with advanced malignanciesP M Fracasso, J S Rader, R Govindan, et al.
British Journal of Cancer|June 9, 2005
Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodarP M Fracasso, K A Blum, M K Ma, et al.
Pageof 1